- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/08 - Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Patent holdings for IPC class A61P 15/08
Total number of patents in this class: 936
10-year publication summary
|
38
|
45
|
30
|
50
|
87
|
56
|
77
|
83
|
103
|
23
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ferring B.V. | 705 |
32 |
| Takeda Pharmaceutical Company Limited | 2961 |
18 |
| Lipocine Inc. | 91 |
12 |
| Life Biosciences Inc. | 20 |
12 |
| Jumpstart Fertility Pty Ltd | 14 |
12 |
| Kissei Pharmaceutical Co., Ltd. | 215 |
10 |
| Merck Patent GmbH | 5909 |
8 |
| Banyu Pharmaceutical Co., Ltd. | 107 |
8 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
8 |
| Daiichi Sankyo Company, Limited | 1829 |
8 |
| Centre National de La Recherche Scientifique | 9632 |
7 |
| Bayer Schering Pharma AG | 460 |
7 |
| Kyoto University | 2732 |
7 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 66 |
7 |
| Pharchoice Therapeutics Inc | 22 |
7 |
| Aarhus Universitet | 370 |
6 |
| Assistance Publique - Hopitaux de Paris | 933 |
6 |
| Inocells B.V. | 6 |
6 |
| Novartis AG | 11238 |
5 |
| Bayer Pharma AG | 1096 |
5 |
| Other owners | 745 |